Executive Board
Programme
Join the global vascular and endovascular community
Charing Cross (CX) Symposium 2027 returns for its 49th year on 6 – 8 April 2027 at Olympia, London. Come and join us as we welcome the largest international community of clinicians, educators, innovators and industry partners in vascular disease management.
Across three days, CX Symposium will feature a physician-led scientific programme built around lively debate, peer-to-peer exchange, and an audience as expert as those presenting. With 500+ presentations, 300+ discussions, hands-on workshops, podium-first data, live and edited cases and an exhibition, CX Symposium brings together international speakers and the future leaders of vascular care to interrogate the evolving evidence base and its practical implications for best patient outcomes.
Registration opens soon.
CX Co-Chairs
Latest CX news
TEVAR performed outside the IFU has “dramatically worse outcomes”
Dittmar Boeckler (Heidelberg, Germany) tells CX Live that treating patients with thoracic endovascular aortic repair (TEVAR) outside the instructions for use (IFU) has a dramatic effect on patient outcomes after the procedure. “We observed [...]
New MIMICS-2 trial data show helical stents provide durable treatment of diseased femoropopliteal arteries
New data from the MIMICS-2 trial show the BioMimics 3D stent, which mimics natural vascular curvature, remains safe and effective for patients with symptomatic atherosclerotic disease of the femoropopliteal arteries two years after implantation. [...]
Multicentre dataset reveals the added value of diffusion-weighted imaging in TEVAR practice
Novel data from the Stroke from Thoracic Endovascular Repair (STEP) collaborators has provided insight into current practice of thoracic endovascular aortic repair (TEVAR), and the future role of diffusion-weighted magnetic resonance imaging (DW-MRI) in [...]





